NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.36M | 15.47M | 15.89M | 16.03M | 17.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.36M | 15.47M | 15.89M | 16.03M | 17.08M |
| Cost of Revenue | 13.25M | 12.62M | 12.97M | 12.97M | 13.70M |
| Gross Profit | 3.11M | 2.84M | 2.91M | 3.06M | 3.38M |
| SG&A Expenses | 1.97M | 1.83M | 2.51M | 2.30M | 2.18M |
| Depreciation & Amortization | 410.50K | 390.50K | 403.80K | 404.40K | 414.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.63M | 14.85M | 15.88M | 15.68M | 16.29M |
| Operating Income | 724.50K | 619.90K | 5.00K | 355.00K | 784.20K |
| Income Before Tax | 571.00K | 336.50K | -271.10K | 18.20K | 354.20K |
| Income Tax Expenses | -609.80K | 64.00K | -31.60K | 86.40K | 107.00K |
| Earnings from Continuing Operations | 1.18M | 272.50K | -239.60K | -68.20K | 247.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -59.80K | -47.50K | -53.80K | -42.80K | -60.70K |
| Net Income | 1.12M | 225.10K | -293.40K | -111.10K | 186.50K |
| EBIT | 724.50K | 619.90K | 5.00K | 355.00K | 784.20K |
| EBITDA | 1.14M | 1.01M | 594.30K | 759.40K | 1.20M |
| EPS Basic | 0.02 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.02 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 56.33M | 56.29M | 56.21M | 56.45M | 56.57M |
| Average Diluted Shares Outstanding | 60.27M | 59.29M | 56.21M | 58.26M | 58.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |